Patent and Trademark Office June 28, 2023 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Grant of Interim Extension of the Term of U.S. Patent No. 7,517,522; Recombinant ADAMTS13 (rADAMTS13), a Recombinant A Disintegrin and Metalloprotease With Thrombospondin Type-1 Motifs 13
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,517,522 ('522 patent).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.